New anesthesia drug may offer safer sedation for heart valve patients
NCT ID NCT05881291
First seen Jan 16, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tested a newer sedative called ciprofol against the standard drug propofol for patients undergoing a minimally invasive heart valve replacement (TAVR). The goal was to see if ciprofol causes fewer drops in blood pressure and less injection pain. 124 older adults (ages 60-85) took part. Results may help make anesthesia safer and more comfortable for this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.